Cav1 is involved in hepatocellular carcinoma and hepatocellular differentiation through its activation of MAPK signaling [64, 65], and inhibition of Cav1 is associated with the anti-inflammatory effects of some drugs [66–68]. This evidence concerns the gene CAV1 and hepatocellular carcinoma.